These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21512404)

  • 1. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
    Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
    J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
    Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
    Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
    Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.
    Aoki T; Hanamiya M; Uramoto H; Hisaoka M; Yamashita Y; Korogi Y
    Radiology; 2012 Aug; 264(2):590-6. PubMed ID: 22653188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma.
    Yano M; Sasaki H; Kobayashi Y; Yukiue H; Haneda H; Suzuki E; Endo K; Kawano O; Hara M; Fujii Y
    J Thorac Oncol; 2006 Jun; 1(5):413-6. PubMed ID: 17409892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
    Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
    AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced lung adenocarcinoma harboring a mutation of the epidermal growth factor receptor: CT findings after tyrosine kinase inhibitor therapy.
    Choi CM; Kim MY; Lee JC; Kim HJ
    Radiology; 2014 Feb; 270(2):574-82. PubMed ID: 24086072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma.
    Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K
    J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Taniguchi M; Tonami H; Ueda Y; Sakuma T
    Asian Pac J Cancer Prev; 2014; 15(2):657-62. PubMed ID: 24568474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
    Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Ground Glass Opacity Ratio in CT Images Can Predict Tumor Invasiveness of Stage IA Lung Cancer.
    Yu WS; Hong SR; Lee JG; Lee JS; Jung HS; Kim DJ; Chung KY; Lee CY
    Yonsei Med J; 2016 Sep; 57(5):1131-8. PubMed ID: 27401643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.